Thursday, March 28, 2019

Diversity at Novartis Essay -- Novartis Diversity Strategy

Diversity is vital to the success of todays melodic phrase model. Companies small and large have take the standd benefits from an economic standpoint as salubrious as talent commission perspective. Canas & Sondak outline four pillars of switch necessary for a successful program. These pillars are described as demonstrate leadership support, engage employees as partners, integrate diversity with management practices and link diversity goals to avocation goals (Canas & Sondak, 2014). Novartis as a global companion validates the theory to lead diversity within its organization. Company ProfileNovartis is well known as a pharmaceutic company and emerging health care solutions provider. It is engaged in the research, development, manufacture and marketing of branded drugs, generic pharmaceutical products and preventive vaccines, diagnostic tools and consumer health products (Novartis AG, 2013). Novartis is uniquely positioned with a wide breadth of product offerings under one umbrella providing innovation and a alter product offering to the marketplace. Its competitors are GlaxoSmith Kline, Bayer, Eli Lily, Merck & Co. and Johnson and Johnson to name a few. A walloping player in the field, Novartis has annual revenue of 57.9 billion. The company is headquartered in Basel, Switzerland and employees nigh 136,000 associates and operates in more than 140 countries around the world (Novartis Annual bailiwick, 2013). Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz. Geigy started in 1798 selling dyes, chemicals and drugs of all kinds. In the meanwhile a competitor in the marketplace, Alexander Clavel is producing and selling his silk dyes which eventually release as Ciba (Chemical Industry Basel). S... ...and Inclusion a Priority. Profiles in Diversity Journal, 14(2), 52Novartis Annual Report (2013). Retrieved from http// Company History (2013). Retrieved from http// Diversity and Inclusion Report (2012). Retrieved from http//www.novartis.comNovartis AG SWOT Analysis. (2013). Novartis AG SWOT Analysis, 1-8.Novartis Foundation (2013). Biography of Daniel Vasella. Retrieved from http// platform/content/element/298/cv_daniel_vasella.pdfRoyal, M. A., & Stark, M. J. (2006). Why some companies excel at conducting business globally. Journal of Organizational Excellence, 25(4), 3-10.Waltmann, F. (2013). East Meets Best Developing Novartis Talent in Asia. Chief Learning Officer, 12(6), 68-72.

No comments:

Post a Comment